Q4 2024 Earnings Call Transcript February 4, 2025 Amgen Inc. beats earnings expectations. Reported EPS is $5.31, expectations ...

Amgen posted a higher quarterly profit on Tuesday as product sales rose 11% and said late-stage studies of key obesity drug ...

Amgen posted a higher quarterly profit on Tuesday, driven by an 11% rise in product sales, and said late-stage studies of key ...

Amgen (NASDAQ:AMGN) today announced financial results for the fourth quarter and full year of 2024 versus comparable periods in 2023.

Presentation Unidentified Speaker Thank you. Thank you, Julianne. Good afternoon, everyone, and welcome to our 4th-quarter ...

That would steal a march on rival, once-monthly PCSK9 inhibitors – Amgen’s Repatha (evolocumab) and Sanofi/Regeneron’s Praluent (alirocumab) – which have been available for some years but ...

While Amgen has data showing Repatha can reduce heart attacks and ... and have since been made available in patient-friendly monthly jabs, but neither have produced the blockbuster-level sales ...

The Business Research Company's Repatha Global market Report 2025 – Market Size, Trends, And Forecast 2025-2034 Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase ...

AMC Theatres is hiking the price of Stubs A-List, the cinema chain’s monthly movie subscription membership. But film fanatics are getting a greater value for their money, too. They’ll receive ...

The drug, given by injection once monthly or less often, was shown in a mid-stage trial to help overweight or obese patients shed up to 20% of their body weight. Amgen research and development head ...

The rising popularity of monthly dividend ETFs has prompted major hedge fund firms to offer a large selection. Investors have numerous options, but knowing the factors to analyze in monthly ...

For most households, a monthly subscription would suffice for multiple users and devices. However, if you’re looking to save some extra cash on subscription costs, then an annual plan may be the ...